AAAAAA
Results:
1-24
|
Results: 24
Authors:
Hondermarck, H
Vercoutter-Edouart, AS
Revillion, F
Lemoine, J
El-Yazidi-Belkoura, I
Nurcombe, V
Peyrat, JP
Citation: H. Hondermarck et al., Proteomics of breast cancer for marker discovery and signal pathway profiling, PROTEOMICS, 1(10), 2001, pp. 1216-1232
Authors:
Hondermarck, H
Vercoutter-Edouart, AS
Lemoine, J
Peyrat, JP
Citation: H. Hondermarck et al., Proteome analysis reveals the tumor suppressor function of 14-3-3 sigma, M S-MED SCI, 17(6-7), 2001, pp. 796-797
Authors:
Hondermarck, H
Peyrat, JP
Citation: H. Hondermarck et Jp. Peyrat, Classifying tumors - Proteomic analysis, BIOFUTUR, 2001(212), 2001, pp. 43-44
Authors:
Descamps, S
Toillon, RA
Adriaenssens, E
Pawlowski, V
Cool, SM
Nurcombe, V
Le Bourhis, XF
Boilly, B
Peyrat, JP
Hondermarck, H
Citation: S. Descamps et al., Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways, J BIOL CHEM, 276(21), 2001, pp. 17864-17870
Authors:
Vercoutter-Edouart, AS
Czeszak, X
Crepin, M
Lemoine, J
Boilly, B
Le Bourhis, X
Peyrat, JP
Hondermarck, H
Citation: As. Vercoutter-edouart et al., Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells, EXP CELL RE, 262(1), 2001, pp. 59-68
Authors:
Descamps, S
Pawlowski, V
Revillion, F
Hornez, L
Hebbar, M
Boilly, B
Hondermarck, H
Peyrat, JP
Citation: S. Descamps et al., Expression of nerve growth factor receptors and their prognostic value in human breast cancer, CANCER RES, 61(11), 2001, pp. 4337-4340
Authors:
Vercoutter-Edouart, AS
Lemoine, J
Le Bourhis, X
Louis, H
Boilly, B
Nurcombe, V
Revillion, F
Peyrat, JP
Hondermarck, H
Citation: As. Vercoutter-edouart et al., Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells, CANCER RES, 61(1), 2001, pp. 76-80
Authors:
Vercoutter-Edouart, AS
Peyrat, JP
Lemoine, J
Hondermarck, H
Citation: As. Vercoutter-edouart et al., Proteomic analysis: why and how?, B CANCER, 88(7), 2001, pp. 663-670
Authors:
Pawlowski, V
Revillion, F
Hebbar, M
Hornez, L
Peyrat, JP
Citation: V. Pawlowski et al., Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay, CLIN CANC R, 6(11), 2000, pp. 4217-4225
Authors:
Revillion, F
Pawlowski, V
Hornez, L
Peyrat, JP
Citation: F. Revillion et al., Glyceraldehyde-3-phosphate dehydrogenase gene expression in human breast cancer, EUR J CANC, 36(8), 2000, pp. 1038-1042
Authors:
Hebbar, M
Peyrat, JP
Citation: M. Hebbar et Jp. Peyrat, Significance of soluble endothelial molecule E-selectin in patients with breast cancer, INT J B MAR, 15(1), 2000, pp. 15-21
Authors:
Pawlowski, V
Revillion, F
Hornez, L
Peyrat, JP
Citation: V. Pawlowski et al., A real-time one-step reverse transcriptase-polymerase chain reaction method to quantify c-erbB-2 expression in human breast cancer, CANCER DET, 24(3), 2000, pp. 212-223
Authors:
Blanckaert, VD
Hornez, L
Hebbar, M
Louchez, MM
Hondermarck, H
Peyrat, JP
Citation: Vd. Blanckaert et al., Distribution and prognostic value of the fibroblast growth factor-2 low-affinity binding sites in human breast cancer, ANTICANC R, 20(5C), 2000, pp. 3913-3918
Authors:
Laud, K
Gourdou, I
Belair, L
Peyrat, JP
Djiane, J
Citation: K. Laud et al., Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues, INT J CANC, 85(6), 2000, pp. 771-776
Authors:
Vercoutter-Edouart, AS
Lemoine, J
Smart, CE
Nurcombe, V
Boilly, B
Peyrat, JP
Hondermarck, H
Citation: As. Vercoutter-edouart et al., The mitogenic signaling pathway for fibroblast growth factor-2 involves the tyrosine phosphorylation of cyclin D2 in MCF-7 human breast cancer cells, FEBS LETTER, 478(3), 2000, pp. 209-215
Authors:
Mirjolet, JF
Barberi-Heyob, M
Didelot, C
Peyrat, JP
Abecassis, J
Millon, R
Merlin, JL
Citation: Jf. Mirjolet et al., Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status, BR J CANC, 83(10), 2000, pp. 1380-1386
Authors:
Hebbar, M
Peyrat, JP
Hornez, L
Hatron, PY
Hachulla, E
Devulder, B
Citation: M. Hebbar et al., Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis, ARTH RHEUM, 43(4), 2000, pp. 889-893
Authors:
Mazoyer, S
Leary, J
Kirk, J
Fleischmann, E
Wagner, T
Claes, K
Messiaen, L
Foulkes, W
Desrochers, M
Simard, J
Phelan, CM
Kwan, E
Narod, SA
Vahteristo, P
Nevanlinna, H
Durando, X
Bignon, YJ
Peyrat, JP
Bonnardel, C
Sinilnikova, OM
Puget, N
Lenoir, GM
Mazoyer, S
Audoynaud, C
Goldgar, D
Maugard, C
Caux, V
Gad, S
Stoppa-Lyonnet, D
Nogues, C
Lidereau, R
Machavoine, C
Bressac-de Paillerets, B
Kuschel, B
Betz, B
Niederacher, D
Beckmann, MW
Hamann, U
Gayther, SA
Ponder, BAP
Robinson, M
Taylor, GR
Bishop, T
Catteau, A
Solomon, E
Cohen, B
Steel, M
Collins, N
Stratton, M
van der Looij, M
Olah, E
Miller, NJ
Barton, DE
Sverdlov, RS
Friedman, E
Radice, P
Montagna, M
Sensi, E
Caligo, M
van Eijk, R
Devilee, P
van der Luijt, R
Heimdal, K
Moller, P
Borg, A
Diez, O
Cortes, J
Domenech, M
Baiget, M
Osorio, A
Benitez, J
Borg, A
Maillet, P
Sappino, AP
Ozdag, H
Ozcelik, T
Ozturk, M
Rohlfs, EM
Boyd, J
McDermott, D
Offit, K
Unger, M
Nathanson, K
Weber, BL
Sellers, TA
Hampton, E
Couch, FJ
Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212
Authors:
Hebbar, M
Revillion, F
Louchez, MM
Fournier, C
Bonneterre, J
Peyrat, JP
Citation: M. Hebbar et al., Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients, CLIN CANC R, 5(6), 1999, pp. 1427-1433
Authors:
Preudhomme, C
Revillion, F
Merlat, A
Hornez, L
Roumier, C
Duflos-Grardel, N
Jouet, JP
Cosson, A
Peyrat, JP
Fenaux, P
Citation: C. Preudhomme et al., Detection of BCR-ABL transcripts in chronic myeloid leukemia (CML) using a'real time' quantitative RT-PCR assay, LEUKEMIA, 13(6), 1999, pp. 957-964
Authors:
Eisinger, F
Nogues, C
Guinebretiere, JM
Peyrat, JP
Bardou, VJ
Noguchi, T
Vennin, P
Sauvin, R
Lidereau, R
Birnbaum, D
Jacquemier, J
Sobol, H
Citation: F. Eisinger et al., Novel indications for BRCA1 screening using individual clinical and morphological features, INT J CANC, 84(3), 1999, pp. 263-267
Authors:
Jacquemier, J
Eisinger, F
Nogues, C
Sun, ZZ
Guinebretiere, JM
Peyrat, JP
Geneix, J
Lidereau, R
Birnbaum, D
Sobol, H
Citation: J. Jacquemier et al., Histological type and syncytial growth pattern affect E-cadherin expression in a multifactorial analysis of a combined panel of sporadic and BRCA1-associated breast cancers, INT J CANC, 83(1), 1999, pp. 45-49
Authors:
Widschwendter, M
Widschwendter, A
Welte, T
Daxenbichler, G
Zeimet, AG
Bergant, A
Berger, J
Peyrat, JP
Michel, S
Doppler, W
Marth, C
Citation: M. Widschwendter et al., Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitro, BR J CANC, 79(2), 1999, pp. 204-210
Authors:
Blanckaert, VD
Hebbar, M
Louchez, MM
Vilain, MO
Schelling, ME
Peyrat, JP
Citation: Vd. Blanckaert et al., Basic fibroblast growth factor receptors and their prognostic value in human breast cancer, CLIN CANC R, 4(12), 1998, pp. 2939-2947
Risultati:
1-24
|